Take a look at this:
Insiders Are Buying the Blood in This Biopharma Stock
It’s one of the biggest names in the biopharmaceutical space…
And it’s down 40% off all time highs.
It’s not just this company, though. The biotech …
Take a look at this:
Insiders Are Buying the Blood in This Biopharma Stock
It’s one of the biggest names in the biopharmaceutical space…
And it’s down 40% off all time highs.
It’s not just this company, though. The biotech …
We’re sliding into the home stretch of 2023 with some serious gains thanks to our stock roadmap strategy…
Coinbase (Nasdaq: COIN) has gone parabolic on some crypto-related catalysts.
There’s regulatory burdens that could be eased soon with the introduction of …
Take a look at this:
Targeting 8X Upside on a 3D Stock
That’s an anti-junta rebel fighter in Myanmar.
And that weapon slung over his shoulder? It was made with a 3D printer.
It’s an FGC-9 – a gun specifically …
Take a look at this:
We’re Buying a Legacy Brand With Legs to Run
That’s Abercrombie & Fitch (NYSE: ANF), a clothing retailer that’s rallied more than 180% on the year.
Abercrombie was huge in the ‘90s. So were these …
There’s a bull market somewhere…
This Juice Looks Worth the Squeeze
This is a weekly chart for orange juice futures. Due to a bad harvest in Florida, this commodity is seeing a squeeze.
(Yes, pun intended. You can’t talk about …
This chart crossed my desk this morning…
Fresh from the “we are entirely too top heavy” department:
How We’re Leveraging the Largest Misallocation of Capital in Modern Finance
Two companies, Apple and Microsoft, are currently worth more than four entire …